Enprofylline

Enprofylline
Identifiers
CAS Number 41078-02-8 YesY
PubChem (CID) 1676
DrugBank DB00824 N
ChemSpider 1613 YesY
UNII DT7DT5E518 N
ChEBI CHEBI:126237 N
ChEMBL CHEMBL279898 N
ECHA InfoCard 100.050.166
Chemical and physical data
Formula C8H10N4O2
Molar mass 194.190 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Enprofylline (3-Propylxanthine) is a xanthine derivative used in the treatment of asthma, which acts as a bronchodilator. It acts primarily as a competitive nonselective phosphodiesterase inhibitor with relatively little activity as a nonselective adenosine receptor antagonist.[1][2]

References

  1. Lunell E, Svedmyr N, Andersson KE, Persson CG (1982). "Effects of enprofylline, a xanthine lacking adenosine receptor antagonism, in patients with chronic obstructive lung disease". European Journal of Clinical Pharmacology. 22 (5): 395–402. doi:10.1007/bf00542541. PMID 6288396.
  2. Laursen LC (December 1987). "Anti asthmatic effects and pharmacokinetics of enprofylline--a new xanthine derivate". Danish Medical Bulletin. 34 (6): 289–97. PMID 3325233.
This article is issued from Wikipedia - version of the 5/24/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.